Thus, blockage of FGF-2 has been proposed as a potential adjunct therapy to treat C. albicans infection (50), though further studies are warranted to investigate the role of FGF-2 in Candida endogenous endophthalmitis. Here, FGF2 is linked to endophthalmitis.